Proposal for the administration of metformin in patients with chronic kidney disease

2012 ◽  
Vol 153 (39) ◽  
pp. 1527-1535 ◽  
Author(s):  
Zoltán Balogh ◽  
János Mátyus

Metformin is the first-line, widely used oral antidiabetic agent for the management of type 2 diabetes. There is increasing evidence that metformin use results in a reduction in cardiovascular morbidity and mortality, and might have anticancer activity. An extremely rare, but potentially life-threatening adverse effect of metformin is lactic acidosis, therefore, its use is traditionally contraindicated if the glomerular filtrate rate is below 60 mL/min. However, lactic acidosis is always associated with acute events, such as hypovolemia, acute cardiorespiratory illness, severe sepsis and acute renal or hepatic failure. Furthermore, administration of insulins and conventional antihyperglycemic agents increases the risk of severe hypoglycemic events when renal function is reduced. Therefore, the magnitude of the benefit of metformin use would outweigh potential risk of lactic acidosis in moderate chronic renal disease. After reviewing the literature, the authors give a proposal for the administration of metformin, according to the calculated glomerular filtrate rate. Orv.Hetil., 2012, 153, 1527–1535.

1997 ◽  
Vol 120 (1) ◽  
pp. 137-145 ◽  
Author(s):  
Takao Ikenoue ◽  
Megumi Akiyoshi ◽  
Shoji Fujitani ◽  
Kyoko Okazaki ◽  
Nobuo Kondo ◽  
...  

1989 ◽  
Vol 49 ◽  
pp. 328
Author(s):  
Mikio Omosu ◽  
Shunsuke Tsutsumi ◽  
Ryuji Yajima ◽  
Shoryo Hayashi

2015 ◽  
Vol 47 (8) ◽  
pp. 2404-2406 ◽  
Author(s):  
C. Rodríguez-Villar ◽  
I. Conget ◽  
J. Ferrer-Fàbrega ◽  
D. Paredes ◽  
A. Ruíz ◽  
...  

Diabetes ◽  
2001 ◽  
Vol 50 (1) ◽  
pp. 131-138 ◽  
Author(s):  
M. C. Munoz ◽  
A. Barbera ◽  
J. Dominguez ◽  
J. Fernandez-Alvarez ◽  
R. Gomis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document